Code HS: 30
D'où | |
La direction de la | |
Où | |
Période | |
Sélection de produits |
Période | Somme |
---|---|
2018 | $18.4 k |
2019 | --- |
Total: | $18.4 k |
Période | Poids, tonnes. |
---|---|
2018 | 1.14 |
2019 | --- |
Total: | 1.14 |
Famille de produits | 2018 | 2019 | ch. | ∑ (2018-2019) | Part |
---|---|---|---|---|---|
06 3001: Glandes et autres organes à usages opothérapiques | --- | --- | --- | --- | 0% |
06 3002: Sang humain; sang animal; vaccins, toxines, cultures de micro-organismes | $18.4 k | --- | 100% | $18.4 k | 100% |
06 3003: Médicaments | --- | --- | --- | --- | 0% |
06 3004: Médicaments constitués par des produits mélangés ou non mélangés | --- | --- | --- | --- | 0% |
06 3005: Ouates, gazes, bandes et articles analogues | --- | --- | --- | --- | 0% |
06 3006: Préparations et articles pharmaceutiques visés à la note 4 du présent chapitre | --- | --- | --- | --- | 0% |
Total: | $18.4 k | --- | $18.4 k |
№ | Pays | ∑ (2018-2019) | Part |
---|---|---|---|
1 | Bélarus | $83.9 M | 16% |
2 | Ouzbékistan | $78.6 M | 15% |
3 | Kazakhstan | $65.9 M | 12.5% |
4 | Nigéria | $50.6 M | 9.6% |
5 | Ukraine | $36.8 M | 7% |
6 | Allemagne | $24 M | 4.6% |
7 | Turkménistan | $18.1 M | 3.5% |
8 | Azerbaïdjan | $14.4 M | 2.7% |
9 | Soudan | $13.7 M | 2.6% |
10 | Lituanie | $13.1 M | 2.5% |
11 | Lettonie | $11.8 M | 2.2% |
12 | Moldavie | $11.8 M | 2.2% |
13 | Kirghizistan | $11.1 M | 2.1% |
14 | Tadjikistan | $10.9 M | 2.1% |
15 | République démocratique du Congo | $10.1 M | 1.9% |
... | ... | ... | ... |
83 | Burundi | $21.7 k | 0% |
84 | Sud-Soudan | $21.1 k | 0% |
85 | Maroc | $18.4 k | 0% |
86 | Tanzanie | $17.9 k | 0% |
87 | Émirats arabes unis | $17.9 k | 0% |
... | ... | ... | ... |
Le total de tous les pays: | $526 M | 100% |
№ | Région | ∑ (2018-2019) | Part |
---|---|---|---|
1 | Sankt-Peterburg | $9.2 M | 56.7% |
2 | Vladimirskaya oblast | $3.8 M | 23.6% |
3 | Moskovskaya oblast | $3.1 M | 19.3% |
4 | Belgorodskaya oblast | $45.4 k | 0.3% |
5 | Moskva | $18.4 k | 0.1% |
Dans toutes les régions: | $16.2 M | 100% |